Surrey Heartlands

Joint Formulary & PAD

Letrozole - Breast cancer

You are here : Home > Formulary Search > Letrozole - Breast cancer

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important

1st month supply from specialist team before request for primary care prescribing.

Documentation

Shared Care
Aromatase inhibitors in breast cancer - Amber Star information sheet SWSH Cancer Network - February

PAD Profile

ChemicalSubstance :
Letrozole
Indication :
Breast cancer
Group Name :
Keywords :
Aromatase Inhibitors
Brand Names Include :
Femara
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Letrozole is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Breast cancer.

Committee Recommendations (1)

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Letrozole has been considered by the PCN and has been assigned a BLUE traffic light status.

NOTE - the branded product, Femara, was considered BLACK at the PCN in May 2017.